Loading...
RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.
Highlights

A collection of news and information related to Gilead Sciences Inc. published by this site and its partners.

Sort By: Relevancy | Date | Type
Displaying items 1-12 of 23
» View courant.com items only
    May 17, 2013 |Story| Reuters

  1. U.S. RESEARCH ROUNDUP: Visa, Wal-Mart, Biogen Idec, Walt Disney

    Reuters
    May 17 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S. companies, including Macy's and Biogen Idec on Friday. HIGHLIGHTS * Aruba Networks : FBN, JP Morgan, Needham, Wedbush, Wells Fargo cut rating *...

    Tags: Walmart, Tetra Technologies Incorporated, Cosi Incorporated, NPS Pharmaceuticals Incorporated, Rentals

    2. May 15, 2013 |Story| Reuters

  2. Experimental Gilead drug effective in early-stage leukemia trial

    Reuters
    By Deena Beasley May 15 (Reuters) - An experimental drug from Gilead Sciences Inc shrank tumors in half of leukemia patients whose cancer had returned, according to an early-stage trial that represents a new foray into oncology by the world's biggest...

    Tags: Leukemia, Medical Research, Science and Technology, Medical Specialization, Dana-Farber Cancer Institute

    3. May 13, 2013 |Story| Reuters

  3. U.S. RESEARCH ROUNDUP: AIG, Express Scripts, Eli Lilly, Carlyle Group

    Reuters
    May 13 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S. companies, including AIG, Carlyle Group and Express Scripts, on Monday. HIGHLIGHTS * AIG : Barclays raises to overweight from equal weight -...

    Tags: Walmart, Tower Group Incorporated, Discovery Communications, Inc., Boyd Gaming Corporation, Range Resources Corporation

    4. May 8, 2013 |Story| Reuters

  4. Many in U.S. don't get proper testing for hepatitis C- CDC

    Reuters
    By Julie Steenhuysen NEW YORK, May 8 (Reuters) - Only half of people in the United States who have ever been infected with hepatitis C get proper testing for the liver-destroying disease, according to U.S. health officials. Proper testing is a two-...

    Tags: Medical Research, U.S. Centers for Disease Control and Prevention, Viral Diseases and Infections, Hepatitis C , Merck & Company Incorporated

    5. May 7, 2013 |Story| Reuters

  5. REUTERS SUMMIT-Biotech firms evolve from targets to acquirers

    Reuters
    (For other news from Reuters Health Summit, click on http://www.reuters.com/summit/Health13) * Skyrocketing valuations quash talks * With financing available, many biotechs go it alone * Bankers expect steady flow of $1 bln to $5 bln pharma deals By...

    Tags: Biotechnology, Science and Technology, Economy, Business and Finance, Biogen Idec Incorporated, JPMorgan Chase & Co.

    6. May 3, 2013 |Story| Reuters

  6. U.S. RESEARCH ROUNDUP: Estee Lauder, Actavis, MGM Resorts

    Reuters
    May 3 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S. companies, including Estee Lauder and MGM Resorts, on Friday. HIGHLIGHTS * LinkedIn Corp : BMO, JP Morgan, Canaccord Genuity, others raise...

    Tags: HudBay Minerals Incorporated, Environmental Issues, Energy Partners Limited, Ameren Corporation, Gaming Industry

    7. May 2, 2013 |Story| Reuters

  7. CORRECTED-Gilead profit rises 63 pct, sales of older HIV drugs dip

    Reuters
    (Corrects 3rd paragraph to show Complera sales rose 184 percent, not 10 percent; shows that sales of Stribild totaled $92.1 million, with no prior year comparison, not that they rose 184 percent) May 2 (Reuters) - Gilead Sciences Inc said on Thursday its...

    Tags: New Products, HIV, Truvada, Thomson Corporation, Earnings Forecasts

    8. May 2, 2013 |Story| Reuters

  8. U.S. RESEARCH ROUNDUP: MasterCard, Visa, Facebook, Las Vegas Sands

    Reuters
    May 2 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S. companies, including Visa and Facebook, on Thursday. HIGHLIGHTS * MasterCard Inc : Nomura cuts target price to $593 from $611; rating buy * DXP...

    Tags: Yelp, Inc., Partners (tv program), Genworth Financial Inc, Blackbaud, Markel Corporation

    9. May 2, 2013 |Story| Reuters

  9. US STOCKS SNAPSHOT-Nasdaq up 1 pct as Wall St extends advance

    Reuters
    NEW YORK, May 2 (Reuters) - U.S. stocks extended their advance on Thursday, with the Nasdaq Composite up 1 percent, led by gains in shares of Apple and Gilead Sciences. The Dow Jones industrial average rose 113.46 points or 0.77 percent, to 14,814.41,...

    Tags: NASDAQ, Stock Activities, European Central Bank, Nasdaq Composite, Stock Market

    10. Apr 29, 2013 |Story| Reuters

  10. U.S. RESEARCH ROUNDUP: 3M, Time Warner, Walt Disney, Caterpillar

    Reuters
    April 29 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S. companies, including Time Warner, 3M Co and Caterpillar, on Monday. HIGHLIGHTS * 3M Co : JP Morgan cuts target price to $95 from $97; rating...

    Tags: Republic Services Incorporated, BJ's Restaurants Inc., GFI Group Incorporated, Autoliv Incorporated, Viacom Inc.

    11. Aug 27, 2012 |Story| Reuters

  11. FDA approves Gilead's four-drug HIV treatment

    (Reuters) - U.S. health regulators on Monday approved Gilead Sciences Inc's four-drug combination pill to treat HIV, the virus that causes AIDS.
    Reuters
    (Reuters) - U.S. health regulators on Monday approved Gilead Sciences Inc's four-drug combination pill to treat HIV, the virus that causes AIDS. The four drugs in one pill, which was formerly called the Quad and had been considered one of Gilead's more...

    Tags: U.S. Centers for Disease Control and Prevention, Viral Diseases and Infections, HIV, Hepatitis C , Drugs and Medicines

    12. Jul 16, 2012 |Story| KTLA-LTV

  12. FDA Approves First Ever HIV Prevention Drug

    LOS ANGELES -- Adults who do not have HIV but are at risk of getting the disease will now be able to take a drug to reduce their chance of getting infected.
    KTLA News
    LOS ANGELES -- Adults who do not have HIV but are at risk of getting the disease will now be able to take a drug to reduce their chance of getting infected. For the first time, the U.S. Food and Drug Administration approved a drug for this use on Monday....

    Tags: Medical Research, Viral Diseases and Infections, HIV, Trials, Drugs and Medicines

 1  2 • Next >
Original site for Gilead Sciences Inc. topic gallery.